Update 2008, Q3 Live!

₃P Mulsant

Summary for 2003 [at-glance overview of P Mulsant work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author P Mulsant. According to available data, in 2003 P Mulsant published at least 3 articles. This work was completed in collaboration with several authors including Fabre, S and Monget, P. Many other authors have collaborated with P Mulsant as well. There is no information about the funding or the grants awarded to support this work.

Analysis of the article abstracts and the titles suggests that P Mulsant professional interests are focused around "bone morphogenetic protein", "french genetic programmes" and "prolificacy genes sheep". These might also be referred to as "bone morphogenetic", "morphogenetic protein" or "genetic programmes". Statistical analysis shows that P Mulsant's writing is likely to contains terms "genes", "mutation", "sheep", "patients", "booroola" and "associated".

Unfortunately, there is not enough information to establish P Mulsant affiliation. Luckily, one email address is on file.

EN FR ES RU

leave comment ask question

Other [context-specific ads]

Alternative names (0) [other authors with names similar to P Mulsant]

none

Year 2003 Charts [P Mulsant frequent coauthors and the most common unique vocabulary terms for the selected year]

Historical Performance Charts [graphical overview of P Mulsant publication and funding history for the range of years]

Emails (1) [email addresses extracted from P Mulsant affiliations]

hidden to prevent spam, click here to reveal

P Mulsant Coauthors (15) [all coauthors with the number of joint publications]

2

2

2

2

1

1

1

1

1

1

1

1

1

1

1

Affiliations (3) [condensed summary of the P Mulsant affiliations, the leading number and the color conveys importance]

₁EA 'Ciblage Thérapeutique en Oncologie, Université Lyon 1, Faculté Lyon Sud, 69310, Oullins, France.
₁INRA, Physiologie de la Reproduction et des Comportements, UMR 6073 INRA-CNRS-Université François Rabelais, 37380 Nouzilly, France.
₁INRA, Laboratoire de Génétique Cellulaire, BP 27, 31326 Castanet-Tolosan, France.

Key Opinion Leader In [P Mulsant is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

no keywords assigned

Keywords (32) [keywords assigned to P Mulsant articles by PubMed, the leading number and the color conveys importance]

₃Female | ₂Sheep | ₂Humans | ₂Animals | ₂Receptors, Growth Factor | ₂Protein-Serine-Threonine Kinases | ₂Male | ₂Bone Morphogenetic Protein Receptors, Type I | ₂Genotype | ₁Granulosa Cells | ₁Antineoplastic Agents | ₁Transforming Growth Factor beta | ₁Signal Transduction | ₁Pleural Neoplasms | ₁Point Mutation | ₁Adult | ₁Survival Analysis | ₁Hyperthermia, Induced | ₁Reproduction | ₁Bone Morphogenetic Proteins | ₁Progesterone | ₁Mitomycin | ₁Inhibin-beta Subunits | ₁Ovulation | ₁Middle Aged | ₁France | ₁Cells, Cultured | ₁Activins | ₁Transfection | ₁Combined Modality Therapy | ₁Cell Line | ₁Aged

P Mulsant Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; P Mulsant might be a good expert witness on these terms]

₇genes | ₆mutation | ₆sheep | ₅patients | ₄booroola | ₄associated | ₃itch | ₃morphogenetic | ₃protein | ₃bone | ₃survival | ₃programmes | ₃genetic | ₃long-term | ₃alteration | ₃french | ₃months | ₃gene | ₂bmpr1b | ₂intrathoracic | ₂pleural | ₂bmp-4 | ₂chemohyperthermia | ₂identify | ₂q249r | ₂functionality | ₂treatment | ₂receptor-ib | ₂fibrosarcoma | ₂malignancies | ₂lacaune | ₂results
₃bone morphogenetic | ₃morphogenetic protein | ₃genetic programmes | ₃french genetic | ₃genes sheep | ₃prolificacy genes | ₂pleural malignancies | ₂sheep associated | ₂long-term results | ₂associated alteration | ₂protein receptor-ib | ₂mutation sheep | ₂itch treatment | ₂results intrathoracic | ₂booroola mutation | ₂alteration bone | ₂receptor-ib functionality | ₂chemohyperthermia itch | ₂treatment pleural | ₂intrathoracic chemohyperthermia | ₂fibrosarcoma patients | ₂t2 mesothelioma | ₂sheep french | ₂t1 t2 | ₂mesothelioma patients | ₁follicles overall | ₁mutation q249r | ₁induction activity | ₁form bmpr1b | ₁months lacaune | ₁receptor type | ₁valuable resource
₃bone morphogenetic protein | ₃french genetic programmes | ₃prolificacy genes sheep | ₂morphogenetic protein receptor-ib | ₂sheep associated alteration | ₂protein receptor-ib functionality | ₂associated alteration bone | ₂itch treatment pleural | ₂mutation sheep associated | ₂long-term results intrathoracic | ₂treatment pleural malignancies | ₂booroola mutation sheep | ₂chemohyperthermia itch treatment | ₂intrathoracic chemohyperthermia itch | ₂results intrathoracic chemohyperthermia | ₂alteration bone morphogenetic | ₂genes sheep french | ₂t1 t2 mesothelioma | ₂t2 mesothelioma patients | ₂sheep french genetic | ₁programmes demonstrated variations | ₁limited linkage testing | ₁survival rates respectively | ₁procedure | ₁transfected fecb form | ₁receptor t1 t2 | ₁lacaune gene situated | ₁months t3 t4 | ₁fecb form bmpr1b | ₁genetic programmes long-term | ₁associated segregation several | ₁development ovarian follicles

Reader's Comments (0) [comments posted by readers of P Mulsant profile]